Lov-M Syrup is a combination medication containing Levocetirizine 2.5 mg and Montelukast 4 mg per 5 ml, formulated for the management of allergic conditions. Levocetirizine is a second-generation antihistamine that selectively inhibits peripheral H1 receptors, effectively reducing symptoms such as sneezing, rhinorrhea, nasal itching, and urticaria by blocking the action of histamine. Montelukast is a leukotriene receptor antagonist that prevents leukotriene-mediated bronchoconstriction, inflammation, and mucus production, providing additional relief in conditions like allergic rhinitis and asthma. The synergistic action of these two agents offers comprehensive control of allergic symptoms, improving patient comfort and quality of life. Lov-M Syrup is indicated for the treatment of allergic rhinitis, chronic urticaria, and as adjunct therapy in asthma management in pediatric and adult patients. It is generally well tolerated; however, patients should be monitored for potential side effects including headache, somnolence, gastrointestinal disturbances, and rare neuropsychiatric events. Dosage should be individualized based on age and clinical response, adhering to prescribed guidelines. Lov-M Syrup should be used under medical supervision, with caution advised in patients with hepatic or renal impairment.